Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R., & Batty, G.D., & et al., (2010) 
Introduction
The metabolic syndrome, a constellation of symptoms encompassing central obesity, hypertension, hyperglycaemia, hypertriglyceridaemia, and low HDL-cholesterol, has been associated with increased allcause and cardiovascular disease mortality in a number of populations. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Most studies have focussed on whether the presence of the metabolic syndrome increases all-cause or cardiovascular disease mortality and often do not appear to exclude existing cardiovascular disease, 15 a major determinant of subsequent events. 16 Additionally, the utility of using three or more components to identify the condition, given that a significant proportion of the non-affected population may have up to two risk factors, has yet to be determined, as has the advantage of using the metabolic syndrome over its individual components.
Similarly, the question arises whether those with the condition but with more than the three components required are at greater risk than those who just meet the threshold for diagnosis. In this study we use the well-characterised Vietnam Experience Study to address these issues in a sample of male veterans.
Methods

Participants and procedure
Details of sampling at each stage of data collection performed in 1985/86 are shown in Figure 1 .
Inclusion criteria were: entered military service for the United States of America between January 1, 1965 and December 31, 1971; served only one term of enlistment; served at least 16 weeks of active duty; earned a military specialty other than "trainee" or "duty soldier"; had a military pay grade at discharge no higher than sergeant. Information on place of service and ethnicity was extracted from the military archives. From the subsequent telephone survey, socio-economic position was measured using household income in midlife and the grade from which participants left school. Frequency of alcohol consumption was classified as number of units per week. Smoking habits and marital status were ascertained using standard questions. Participants were asked whether they had a range of physician-diagnosed diseases including hypertension, cancer, coronary heart disease (CHD), and diabetes. 17, 18 Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R., & Batty, G.D., & et al., (2010 
Definition of the metabolic syndrome
The metabolic syndrome and its components were defined using the American Heart Association/National Heart, Lung, and Blood Institute scientific statement. 19 
Statistical analysis
Data from normally distributed parameters are presented as mean ± SD, whereas skewed data were logarithmically transformed and expressed as geometric mean with 95% confidence intervals (95%CIs). added in a hierarchical manner as described in tables 2 and 3. These covariates were chosen a priori as they have all been associated with health outcomes in this dataset. 22, 23 and others (e.g., 24 ) SPSS (version 15.0 for windows, Chicago, IL, USA) was used in the analyses.
Results
Of the 4,256 men with complete data, 56 were excluded due to a history of existing cardiovascular disease, leaving 4,200 who were included in these analyses. The participants were followed-up for a mean duration of 14.7 years, resulting in 61,498 person-years of data. There were a total of 231 (5.5%) deaths from any cause, with 60 resulting from cardiovascular disease ((ICD-9: 390-434,436-448, ICD-10: I00-I78); 67% of which were associated with ischaemic heart disease (ICD-9: 410-414,429.2, ICD-10: I20-I25)). At baseline, 752 participants (17.9%) had metabolic syndrome. As expected those with the metabolic syndrome had increased levels of the components of the syndrome ( Table 1 ). The prevalence of lifestyle factors, smoking and alcohol consumption, were similar between the groups.
Those with the metabolic syndrome generally had lower levels of education.
In Cox proportional hazards regression, having the metabolic syndrome was associated with a doubling of risk of both all-cause and cardiovascular disease mortality (Table 2) . After adjustment for potential confounders (age, alcohol consumption, smoking, total cholesterol, education, ethnicity, marital Compared to those without any components of the metabolic syndrome those with the condition had three times the risk of cardiovascular mortality.
Of the five individual components, hyperglycaemia, obesity, and low HDL-cholesterol levels were all associated with increased all-cause mortality. As in the analyses of metabolic syndrome, adjustment for potential confounding factors had a minimal effect on the risk estimates. However, when the components were mutually adjusted, only hyperglycaemia and obesity remained independent determinants of all-cause mortality, increasing risk by 58% and 57%, respectively. Of the individual components, hyperglycaemia was most strongly associated with cardiovascular disease mortality with a 126% excess risk, and 109% when adjusted for the other metabolic syndrome components. However, for the remaining individual components the relatively small number of deaths from cardiovascular disease meant that despite excess risks of about 60% or more none reached significance in the fully adjusted model. The adjustment for total blood cholesterol attenuated the risk effect estimates, particularly for triglycerides. Mutual adjustment reduced the strength of the associations for the metabolic syndrome components. High blood pressure, as defined by using blood pressure ≥130/85 mm Hg and/or use of antihypertensive medication, showed no evidence of an association with cardiovascular mortality. In part this may be due to the close relationship between ethnic background and hypertension. The black participants had significantly more hypertension (64.0%) when compared to the whites (48.7%) or those of other origin (53.0%, p<0.001).
A total of 2308 (55.0%) had one or two components of the metabolic syndrome. For cardiovascular mortality, there was a clear dose-dependent increase in the hazard ratios with an increasing number of components (Table 2 , Figure 2) , with the presence of a single component non-significantly increasing risk by 71% 95%CI -29, 309%. Only the presence of three (or more) components was associated with significantly increased risk of death, p = 0.036. The risk associated with four or more components was significantly greater than that associated with only three components for both all-cause, Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R. one or two; and three or more components there was a clear significant dose-dependent effect for both allcause and cardiovascular disease mortality ( Table 2 ). For all-cause mortality, risk only appeared to increase in those with three or more components (Table 2, Figure 2 ). To assess whether the composite variable, metabolic syndrome, provided additional predictive information over the individual components, metabolic syndrome was also added to the analyses. For all-cause mortality, only the metabolic syndrome variable remained significant, increasing risk by 81%, 95%CI 6, 11%, p = 0.031. However, in parallel analyses for cardiovascular disease mortality, the model appeared to be invalid as multicollinearity was identified, and the associations are thus not shown. Accordingly, this model may not afford an appropriate test in this instance, and thus the associations are not shown.
A number of other parameters that have been shown in earlier studies to contribute to mortality were also identified as significant predictors of mortality in the current study. 
Discussion
The present analyses of data from middle-aged male veterans indicate that the metabolic syndrome doubles the risk of both all-cause and cardiovascular disease mortality. As such, our results are consistent with the vast bulk of previous studies. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The main outcomes were not attenuated following adjustment for a wide-range of potential confounders. The metabolic syndrome proved to be a stronger predictor of all-cause mortality than its individual components, a result for which there is precedent. 25 The predictive value of the metabolic syndrome was similar whether the other components were included in the hazard model or not, suggesting that in our analysis multicollinearity was not a major issue. This contrasted with the analysis of determinants of cardiovascular mortality. Examination of the model containing the metabolic syndrome and its components, suggested that the hyperglycaemic component was the most informative, and that the metabolic syndrome was non-significantly associated with reduced risk, a result that is almost certainly artefactual. It is therefore important in studies assessing the utility of the syndrome in predicting risk relative to its components to consider the issue of multicollinearity.
The extent of the risk faced by those without the metabolic syndrome but carrying component risk factors remains unclear. In the current study, as the number of metabolic syndrome components deaths also found incremental risk commencing from one risk factor for cardiovascular disease mortality and two components for all-cause mortality consistent with our findings. 2 These data show a continuum of risk, as seen with the individual components, rather than there being a threshold effect occurring at the level used to define the metabolic syndrome.
Hypertension showed no evidence of a relationship with either all-cause or cardiovascular disease mortality. 2 In part this may be due to the close relationship between ethnic background and hypertension.
The black participants had significantly more hypertension when compared to the whites or those of other origin (15 and 11% more, respectively). Therefore in the analyses, adjusting for ethnicity may have removed some of the variance that would have otherwise been attributed to the hypertension risk factor.
However, even in the crude analyses in the increased hazard ratios did not reach significance, suggesting other parameters may be masking the association. Hypertension has been shown to be associated with cardiovascular disease mortality in some, [1] [2] [3] but not all studies. 13, 26 The relationship between hyperglycaemia and mortality is more heterogeneous. Although many studies do not report the associations of the individual components, some reported similar observations to those in the current study with hyperglycaemia being strongly associated with cardiovascular disease 1, 3, 8, 13 and all-cause mortality, 3, 8 with a similar strength of relationship to that exhibited by the metabolic syndrome in these studies. However, in other studies hyperglycaemia was not an independent predictor of mortality. 2, 26 Although some of the variation is likely the result of differing definitions and population structures, duration may also be an issue with those studies finding a stronger effect of glucose, including the current study, tending to have follow-up periods of more than a decade, 3, 8, 13 contrasting those that did not identify an association. 26 Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R. One limitation of the current study is the lack of availability of waist circumference measures.
However, a number of studies have replaced the central obesity criterion for the metabolic syndrome with the BMI threshold for obesity; this is also regarded by the WHO as an acceptable substitute in defining the metabolic syndrome. 21 Another limitation is that in some of the subgroup analyses, the numbers of deaths are small which results in larger confidence intervals. This means that hazard ratios of a similar magnitude to others that are statistically significant do not reach conventional levels of significance.
However, this is not an issue with the primary study outcomes, and was large enough to allow for the assessment of the level of risk of increasing numbers of components of the syndrome. The study was very well characterised which enabled the adjustment of a wide range of potential confounders.
In summary, as the number of metabolic syndrome components increased so did the risk of mortality and even in those defined as having the syndrome those with four components or more were at increased risk of dying relative to those with only three components. The metabolic syndrome was a better predictor of all-cause mortality than its components suggesting additional utility of the parameters in identifying those at greater risk. These important factors have been rarely reported in studies assessing the impact of the syndrome on mortality. Overall, the metabolic syndrome at least doubled the likelihood of all-cause and cardiovascular disease mortality after removal of the effects of potential confounding factors and is clearly a useful measure of identifying those at elevated risk of dying in this population. 
